Inside Ghana’s Pharmaceutical Supply Chain: From Importers to Patients

Introduction: The Lifeline of Healthcare

Behind every medicine that reaches a patient in Ghana lies a complex, multi-layered journey. The pill that a pharmacist hands across the counter in Tamale may have been manufactured in India, imported through Tema Port, stored in a cold chain warehouse in Accra, distributed to a wholesaler in Kumasi, and finally transported to a retail pharmacy in the Northern Region .

This journey—the pharmaceutical distribution chain—is the lifeline of healthcare in Ghana. When it functions well, patients receive essential medicines on time, at affordable prices. When it fails, stockouts occur, counterfeit products infiltrate the market, and lives are put at risk .

Ghana’s pharmaceutical market is valued at approximately USD 438 million (as of mid-2025) , with imports accounting for about 70% of the market and local manufacturing covering the remaining 30% . Understanding how this market is structured—from the manufacturers and importers who supply products to the wholesalers who distribute them and the retail pharmacies who serve patients—is essential for anyone entering the pharmaceutical business or seeking to understand where their medicines come from.

This Accra Street Journal  guide provides a comprehensive breakdown of Ghana’s pharmaceutical distribution chain, examining each tier, the key players, the regulatory framework, and the challenges that make this sector both critical and complex.

The Big Picture: Market Size and Structure

Market Overview

Ghana’s pharmaceutical market is one of the most promising sectors in Sub-Saharan Africa, experiencing notable evolution in recent years. As of 2021, the market’s value reached $433 million, and it has continued to grow. By mid-2025, estimates placed the market at approximately $438 million .

The Import Reliance Reality

Approximately 70% of Ghana’s pharmaceutical market is reliant on foreign medicines and raw materials . This import dependency creates both opportunities and vulnerabilities. On one hand, it means Ghanaian patients have access to a wide range of international products. On the other hand, it exposes the supply chain to currency fluctuations, shipping delays, and global supply disruptions.

The top five import countries—India, China, the United Kingdom, France, and Germany—collectively control about 90% of total import volumes . In 2022, total import volumes for pharmaceuticals reached 21 million kg .

Local Manufacturing: The 30% Solution

Domestic production makes up about 30% of the market share . As of July 2022, there were 32 licensed local pharmaceutical manufacturing facilities in the country specializing in the production of prescribed and over-the-counter drugs .

Notable local manufacturers include:

• Ayrton Drug Manufacturing Company

• Letap Pharmaceutical Limited

• M&G Pharmaceuticals

• Kinapharma

• Danadams

• Entrance Pharmaceutical and Research Center

• Alhaji Yakubu Herbal Company

Some of these players have over 40 pharmaceutical product lines with several retail and distribution outlets nationwide . The government has implemented policies to boost local manufacturing, including the expansion of VAT exemptions on raw materials and the imposition of a ban on over 40 medicines to reserve production exclusively for local manufacturers .

The Public Sector Distribution Channel

The Government’s Role

The Ministry of Health (MoH) and the Ghana Health Service (GHS) serve as key regulators and procurers in the pharmaceutical sector . Pharmaceutical products are distributed to Teaching Hospitals, Government Medical Stores, and other public health facilities through two main procurement systems.

Framework Contracting (Ministry of Health)

The Ministry of Health utilizes a centralized procurement system known as Framework Contracting . This is typically a long-term agreement between the MoH and suppliers, outlining general terms such as price and quantity for smaller recurrent purchasing orders over a specified period.

How it works:

• Pharmaceutical suppliers express interest by submitting bids for consideration

• The MoH reviews these bids, often sharing the contract among bidders to encourage competitive pricing

• Framework contracting is typically renewed annually

Academic Assessment: A study assessing the impact of Framework Agreements on medicine availability at the Upper East Regional Medical Stores found that prior to implementation, stock availability of 65 essential medicines was 100%, with average lead times of 21–22 days. However, after implementation (2017–2024), medicine availability declined, and lead times increased by more than 40% .

National Competitive Tendering (Ghana Health Service)

The Ghana Health Service procures pharmaceutical products through an annual National Competitive Tendering system . In this process, the service publishes a list of pharmaceutical products with specific requirements for potential bidding by suppliers. Interested suppliers submit their bids and quotations, and the Ghana Health Service selects the most suitable supplier for further contractual agreements.

Emergency Procurement Provisions

In cases of shortages within the public sector, Teaching Hospitals, Medical Stores, and other public health facilities are permitted to procure drugs from the private sector. They do so by issuing tenders for bidding, bypassing the Ministry of Health and Ghana Health Service .

The Private Sector Distribution Channel

While the public sector serves government health facilities, the private sector distribution chain is the primary channel through which most Ghanaians access medicines. This chain involves multiple tiers: importers/manufacturers, wholesalers, and retail pharmacies .

Level 1: Manufacturers and Importers

Domestic importers and manufacturers serve as the main sources of pharmaceutical products in the market . As of 2022, the pharmaceutical sector could boast:

• 32 registered pharmaceutical manufacturing facilities

• Over 600 importers of pharmaceutical products

Key Manufacturer Profile: Kofikrom Pharmacy Ltd

Kofikrom Pharmacy Ltd is one of the leading pharmaceutical companies in Ghana, established over two decades ago. The company specializes in the supply of a wide range of pharmaceutical products, including prescription and over-the-counter medications. It serves both the local Ghanaian market and the wider West African region, supplying to hospitals, clinics, and retail pharmacies .

The company has 50 distributorships and 2 outlets in Accra, and produces 85 drugs certified by the Food and Drugs Authority and over 1,000 UK generic medicines in various therapeutic categories, which are accessible in all 16 regions of Ghana . Founded by Dr. Kofi Addo-Agyekum, Kofikrom also manufactures the “Kwality Kare” range of locally produced, affordable products .

Level 2: Wholesale Distributors

Wholesale distributors are the critical link between importers/manufacturers and retail pharmacies. These companies purchase in bulk and supply to pharmacies, hospitals, and clinics across the country.

Key Wholesaler Profile: Unicom Chemist Ltd

Unicom Chemist Ltd has been in the pharmaceutical business since August 1995, providing wholesale and retail services to its valued customers in Ghana. The company is accredited by both the Pharmacy Council of Ghana and the Food and Drugs Authority of Ghana to import, wholesale, distribute, and retail pharmaceuticals in Ghana .

Infrastructure and Reach:

• Head Office: Hse.No.214, Odokor–Winneba Road, Chabaa, Accra

• 7 Retail shops in Dansoman, Abeka Lapaz, Accra Central (Okaishie), Kaneshie, Osu, and Bekwai (Kumasi)

• 6 Wholesale service locations in Bantama (Kumasi), Osu, Dansoman, Korle Bu, Okaishie, and Ashiaman

• Cold storage facility for vaccines and other medications requiring cold storage

• Two backup power generators to ensure constant power supply

• Two cold vans for distribution purposes

Key Accounts:

• Ministry of Health (major client)

• All regional hospitals and Regional Medical Stores

• All District and General Hospitals

• Teaching Hospitals

• Major Private Hospitals

• Other Retail Pharmacies

Staff Strength: 120 employees including 20 pharmacists and 12 other professionals .

Agencies Held: Unicom Chemist holds distributorship agreements with reputable international companies including GlaxoSmithKline (GSK), B Braun of Germany, Becton Dickson International (BD), Intas Pharmaceuticals Ltd India, and is a sub-distributor for Pfizer and Zeneca .

Distribution Fleet: 14 branded delivery vans, one 20ft truck, three motorbikes, and ten saloon cars .

Key Wholesaler Profile: Gokals-Laborex Limited

Created in 2008 from a partnership between CFAO HEALTHCARE and Gokals Pharmacy Limited (operating since 1987), Gokals-Laborex Ltd is a pharmaceutical wholesale company specialized in importing and distributing branded quality medicine to retail pharmacies, hospitals, and wholesalers within Ghana .

Located in Accra, Gokals-Laborex covers all regions in Ghana thanks to strong partnerships with wholesalers in Kumasi, Takoradi, and Tamale .

Level 3: Retail Pharmacies and Chemical Sellers

The final tier of the distribution chain consists of licensed pharmacies and Over-the-Counter Medicine Sellers (OTCMS), who retail products to the final consumer at retail prices .

These retail outlets are regulated by the Pharmacy Council and must meet specific premises and staffing requirements. They serve as the point of contact between the pharmaceutical supply chain and the patient—making their role critical to public health .

Pharmaceutical Importers: The Gateway for Foreign Products

Given the 70% import reliance, pharmaceutical importers play a crucial role in Ghana’s drug supply chain. These companies facilitate the entry of medicines from international manufacturers, primarily from India, China, and Europe .

Devivars is one example of a pharmaceutical importer based in Tema. The company imports medical equipment and pharmaceuticals for clients, with services including importation from China and market access support for local producers seeking to export .

The import process involves multiple steps:

• Sourcing from international manufacturers

• Compliance with FDA registration requirements

• Clearing goods through Tema Port

• Warehousing and quality control

• Distribution to wholesalers and retail pharmacies

The Volza import data indicates active importers such as GR INDUSTRIES, ENTRANCE PHARMACEUTICALS RESEARCH CENTRE, OA J PHARMACEUTICALS, and POKUPHARMA LTD, among others .

The Supply Chain Crisis: Diabetes Medication as a Case Study

While the supply chain structure is well-established, it is not without significant challenges. The diabetes medication crisis serves as a stark illustration of systemic failures.

Port Delays: The First Fault Line

At the Tema Harbour—Ghana’s busiest import gateway—pharmaceutical imports undergo scrutiny from multiple regulatory agencies, including the FDA, the Ghana Revenue Authority, and occasionally the Ghana Standards Authority .

Data from the Ghana Shippers Authority reveals that pharmaceutical imports spend an average of 21 days at port—well beyond the global benchmark of three to seven days. For temperature-sensitive products like insulin, these delays are not just inconvenient—they are disastrous .

Fragmented Distribution

After clearing the port, medications enter a distribution network that is anything but cohesive. Ghana lacks a centralized procurement and distribution mechanism for many essential drugs. Instead, numerous small-scale importers and distributors operate with little oversight .

At the Central Medical Stores in Tema—tasked with supplying public hospitals—a six-month buffer stock is mandated by policy. In practice, budget constraints and procurement inefficiencies mean chronic shortages. Review of internal records shows frequent stockouts of even basic medications like metformin .

The Cost to Patients

When public hospitals run dry, patients often turn to private pharmacies. A month’s supply of insulin in private pharmacies can cost between GH¢400 and GH¢800—two to three times higher than public sector rates when available .

When genuine drugs are inaccessible or unaffordable, the black market steps in. In 2024 alone, over 200 falsified diabetes medication packages were confiscated. Some had no active ingredient, others only partial amounts—and some contained dangerous substitutes .

The World Health Organisation estimates that up to 30 per cent of medications in Ghana may be substandard or counterfeit, with chronic disease treatments particularly vulnerable .

Regulatory Oversight

The pharmaceutical distribution chain operates under the oversight of two key regulatory bodies:

Food and Drugs Authority (FDA)

The FDA was established in 1997 and draws its mandate from Part 6, 7 and 8 of the Public Health Act, 2012 (Act 851), to provide and enforce standards for the manufacture, import, export, sale and distribution of food, drugs, cosmetics, medical devices, and other products .

The FDA’s Drug and Herbal Medicines Registration Directorate processes and grants market authorization for allopathic medicines intended for export and/or sale on the Ghanaian market .

Pharmacy Council of Ghana

The Pharmacy Council licenses all pharmaceutical businesses—importers, wholesalers, and retail pharmacies. It conducts inspections, enforces compliance, and maintains professional standards .

The Council has launched the National Electronic Pharmacy Platform (NEPP) , which allows prescriptions to be uploaded digitally. Pharmacies within a certain radius can respond with availability and pricing—turning access into a competitive, time-sensitive process .

Innovations and the Future

Despite the bleak picture, there are glimmers of progress.

National Electronic Pharmacy Platform (NEPP)

The Pharmacy Council’s NEPP allows prescriptions to be uploaded digitally. Dr (Pharm) Esther Asantewaa Acherekoh, Head of Pharmacy at Manhyia Government Hospital, describes it as “like a digital race. If one pharmacy can’t fulfill the prescription in time, it goes back into the pool for others to claim” .

The system also reduces the risk of counterfeit medications reaching patients since each transaction is traceable and verifiable on the platform .

Moremi AI

The MinoHealth AI Lab in Accra has designed Moremi AI, an artificial intelligence platform that can screen, diagnose, generate treatment plans, and prescribe medications for diabetes. According to Darlington Akogo, CEO of Moremi AI, “this innovation ensures that patients in critical need receive timely medical attention regardless of their location” .

Zipline Drone Delivery

Zipline’s drone delivery network ensures temperature-controlled medications reach remote clinics within 30 minutes of request .

Regional Export Market

Ghana’s pharmaceutical manufacturers are not only serving the domestic market but are also exporting across West Africa. The Pharmaceutical Manufacturers Association of Ghana (PMAG) has called on the government to recover millions of dollars owed by some West African countries for medicines supplied by Ghanaian companies .

Dr Samuel Amo Tobbin, Executive Chairman of the Tobinco Group of Companies and President of PMAG, revealed that debts owed by several Sahel countries—including Burkina Faso, Mali, Senegal, and Ivory Coast—have become a major concern for local manufacturers .

Summary Table: Pharmaceutical Supply Chain at a Glance

Frequently Asked Questions (FAQs)

1. What percentage of Ghana’s pharmaceutical market is imported?
Approximately 70% of Ghana’s pharmaceutical market is reliant on imports, primarily from India, China, the UK, France, and Germany .

2. How many licensed pharmaceutical manufacturers are in Ghana?
As of July 2022, there were 32 licensed local pharmaceutical manufacturing facilities in Ghana .

3. Who are the major wholesale distributors in Ghana?
Major wholesale distributors include Unicom Chemist Ltd (since 1995), Gokals-Laborex Ltd (since 2008), and Kofikrom Pharmacy Ltd .

4. What is the value of Ghana’s pharmaceutical market?
As of mid-2025, Ghana’s pharmaceutical market is valued at approximately USD 438 million .

5. What is the National Electronic Pharmacy Platform (NEPP)?
A digital platform launched by the Pharmacy Council that allows prescriptions to be uploaded electronically. Pharmacies can respond with availability and pricing, reducing the risk of counterfeit medications .

6. What causes pharmaceutical supply chain delays in Ghana?
Key causes include multiple regulatory agency inspections at Tema Harbour (averaging 21 days for clearance), fragmented distribution networks, and lack of centralized procurement mechanisms .

7. How much more do patients pay for medications in private pharmacies?
For medications like insulin, private pharmacy prices can be two to three times higher than public sector rates when available .

8. What is the FDA’s role in pharmaceutical regulation?
The FDA draws its mandate from the Public Health Act, 2012 (Act 851) to enforce standards for the manufacture, import, export, sale, and distribution of drugs in Ghana .

9. Does Ghana export pharmaceuticals to other countries?
Yes. Ghanaian pharmaceutical manufacturers export to West African countries including Burkina Faso, Mali, Senegal, and Ivory Coast. However, these countries owe significant amounts to Ghanaian manufacturers .

10. What innovations are improving Ghana’s pharmaceutical supply chain?
Key innovations include the National Electronic Pharmacy Platform (NEPP), Moremi AI for diabetes diagnosis and treatment, and Zipline’s drone delivery network for temperature-controlled medications .

Conclusion From ASJ

Ghana’s pharmaceutical supply chain is a complex, multi-layered system that connects international manufacturers and local producers to the patients who need medicines. The chain involves over 600 importers, 32 local manufacturers, numerous wholesale distributors, and thousands of retail pharmacies and chemical sellers .

Yet the system faces significant challenges. Port delays, fragmented distribution, payment delays, and counterfeit drugs all threaten the availability and affordability of essential medicines. For patients with chronic conditions like diabetes, these failures can mean the difference between life and death .

But there is reason for optimism. The government has committed to positioning Ghana as a pharmaceutical hub in Africa . Digital innovations like the NEPP and Moremi AI are beginning to scale. Zipline’s drone delivery network is reaching remote clinics. And local manufacturers are expanding their capacity and regional reach .

The journey from port to patient is long. But with continued investment in infrastructure, regulation, and innovation, Ghana’s pharmaceutical supply chain can become a model for the continent.

Source: Accra Street Journal 

Last Updated on April 20, 2026 by Samuel Kwame Boadu

Samuel Kwame Boadu

Samuel Kwame Boadu is a Ghanaian media entrepreneur and storyteller with a passion for amplifying urban voices and uncovering everyday truths. He is the Editor-in-Chief and Founder of Accra Street Journal, a dynamic digital platform dedicated to capturing the pulse of Ghana’s capital—its people, culture, challenges, business, sports and innovations.

accrastreetjournal.com/